Taiwan FDA registration a1033f2eab4206f9fc1d2a11b189bcec

Anminine rupture of membranes (placental microglobulin) detector (sterilization)

TW: 〝安敏寧〞胎膜破裂(胎盤微球蛋白)檢測劑(滅菌)

Taiwan·Risk Class 1·QIAGEN·Registered Dec 07, 2011 – Dec 07, 2021Cancelled

Registration details

Analysis ID: a1033f2eab4206f9fc1d2a11b189bcec
Customs Code: DHA04401115405

Company information

Manufacturer: QIAGEN
Manufacturer Country: United States
Authorized Representative: A-STRONG CO., LTD.

Product details

Intended Use: Limited to the first level of identification range of the Measures for the Administration of Medical Devices "Uric pH (Non-quantitative) Test System (A.1550)".
Product Type (Level 1): A Clinical chemistry and clinical toxicology
Product Type (Level 2): A.1550 Uric pH (non-quantitative) testing system
Import Information: QMS/QSD;; 輸入

Dates and status

Registration Date: Dec 07, 2011
Expiry Date: Dec 07, 2021
Cancellation Date: Sep 23, 2023

Cancellation information

Status: Logged out
Reason: 自行鍵入

About this record

Access comprehensive regulatory information for Anminine rupture of membranes (placental microglobulin) detector (sterilization) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number a1033f2eab4206f9fc1d2a11b189bcec and manufactured by QIAGEN. The authorized representative in Taiwan is A-STRONG CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.